References
- Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric 2015;18:483–91
- Stavraka C, Maclaran K, Gabra H, et al. A study to evaluate the cause of bone demineralization in gynecological cancer survivors. Oncologist 2013;18:423–9
- Lammerink EA, de Bock GH, Schröder CP, Mourits MJ. The management of menopausal symptoms in breast cancer survivors: case-based approach. Maturitas 2012;73:265–8
- Ulrich L. HRT after endometrial cancer – is it safe? Maturitas 2014;79:237–8
- Li D, Ding CY, Qiu LH. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: A systematic review and meta-analysis. Gynecol Oncol 2015;139:355–62
- Holmberg L, Anderson H; HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet 2004;363:453–5
- von Schoultz E, Rutqvist LE; Stockholm Breast Cancer Study Group. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 2005;97:533–5